Effects of Puerarin on the Ovariectomy-Induced Depressive-Like Behavior in ICR Mice and Its Possible Mechanism of Action.
Ariyawan TantipongpiradetOrawan MonthakantiratOnchuma VipatpakpaiboonCharinya KhamphukdeeKaoru UmeharaHiroshi NoguchiHironori FujiwaraKinzo MatsumotoNazim SekerogluAnake KijjoaYaowared ChulikhitPublished in: Molecules (Basel, Switzerland) (2019)
Daily treatment of ovariectomized (OVX) ICR mice with puerarin, a glycosyl isoflavone isolated from the root bark of Pueraria candollei var. mirifica, and 17β-estradiol attenuated ovariectomy-induced depression-like behavior, as indicated by a decrease in immobility times in the tail suspension test (TST) and the forced swimming test (FST), an increase in the uterine weight and volume, a decrease in serum corticosterone levels, and dose-dependently normalized the downregulated transcription of the brain-derived neurotrophic factor (BDNF) and estrogen receptor (Erβ and Erα) mRNAs. Like 17β-estradiol, puerarin also inhibited ovariectomy-induced suppression of neurogenesis in the dentate gyrus of the hippocampus (increased the number of doublecortin (DCX)-immunosuppressive cells). These results suggest that puerarin exerts antidepressant-like effects in OVX animals, possibly by attenuating the OVX-induced hyperactivation of the HPA axis and/or normalizing the downregulated transcription of BDNF and ER mRNA in the brain.
Keyphrases
- estrogen receptor
- high glucose
- diabetic rats
- physical activity
- drug induced
- bone loss
- type diabetes
- body mass index
- adipose tissue
- stress induced
- cell proliferation
- signaling pathway
- multiple sclerosis
- cell death
- breast cancer cells
- brain injury
- major depressive disorder
- cognitive impairment
- insulin resistance
- weight gain
- pi k akt
- sleep quality